Inclusive of all taxes
Bromocriptine Mesylate Tablets IP 2.5 mg are precision-formulated pharmaceutical tablets designed specifically for the treatment and management of gynecological disorders. Manufactured by IndiGlobal Exports under stringent WHO-GMP and pharmacopoeial IP standards, these tablets ensure consistent dosage, high therapeutic efficacy, and compliance with international export requirements. The tablet formulation is tailored to treat conditions such as hyperprolactinemia, amenorrhea, and other hormone-related gynecological disorders effectively. Packaged in export-grade blister or strip packaging, this product is ideal for hospitals, clinics, and pharmaceutical distributors operating in regulated and semi-regulated international markets. Each batch undergoes strict quality control to maintain purity, potency, and stability throughout its shelf life, thereby providing healthcare professionals a reliable option for gynecologic therapies.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Bromocriptine Mesylate |
| Dosage Strength | 2.5 mg per tablet |
| Pharmacopoeia Standards | Indian Pharmacopoeia (IP) compliant |
| Therapeutic Use | Management of gynecology conditions including hyperprolactinemia and menstrual disorders |
| Manufacturing Standards | Produced in WHO-GMP certified manufacturing facilities |
| Packaging Type | Export-grade blister or strip packs |
| Intended Market | Global regulated and semi-regulated pharmaceutical export markets |
| Shelf Life | Compliant with regulatory standards, typically 2 years |
| Manufacturer | IndiGlobal Exports |
| Dosage Form | Oral tablet for ease of administration and dosage accuracy |
| Attributes | Description |
|---|---|
| Product Category | Gynecology |
| Formulation | Tablet |
| Active Pharmaceutical Ingredient (API) | Bromocriptine Mesylate IP 2.5 mg |
| Packaging Details | Export-grade blister or strip packaging |
| Shelf Life Duration | As per regulatory standards (usually 24 months) |
| Storage Conditions | Store in a cool, dry place away from light |
| Compliance | WHO-GMP and Indian Pharmacopoeia IP standards |
| Manufacturer Name | IndiGlobal Exports |
| Intended Use | Treatment of hormone-related gynecology conditions |
| Dosage and Administration | Orally administered as per physician’s prescription |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Yes, these tablets are manufactured under WHO-GMP certified facilities and comply with Indian Pharmacopoeia standards, making them suitable for export to both regulated and semi-regulated markets.
This formulation is indicated for managing hormone-related gynecological disorders such as hyperprolactinemia, amenorrhea, and other menstrual irregularities.
Each tablet is manufactured in a controlled environment with exacting pharmaceutical standards to provide consistent 2.5 mg dosing of Bromocriptine Mesylate.
The tablets are packaged in export-grade blisters or strip packs designed for bulk supply and institutional pharmaceutical distribution.
Yes, it adheres strictly to Indian Pharmacopoeia (IP) quality standards and is produced in GMP-compliant facilities aligned with WHO guidelines.
Brand: indiglobal exports
Country Of Origin: India
Bromocriptine Mesylate Tablets IP 2.5 mg is a pharmaceutical product indicated for gynecology treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Bromocriptine Mesylate Tablets IP 2.5 mg is developed for the effective management of gynecology conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with gynecology indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
